MCM
BSTC

McKinley Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

McKinley Capital Management’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-33,615
Closed -$1.19M – 363
2014
Q3 		$1.19M Buy
+33,615
New +$987K 0.05% 201

Other funds holding BSTC

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

McKinley Capital Management's BSTC Position: Q4 2014 in Review

McKinley Capital Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2014, closing a stake of 33,615 shares — an estimated $1.19M sold.

McKinley Capital Management first reported a position in BSTC in Q3 2014 and held it in 1 quarter. The position peaked at $1.19M in Q3 2014. 85 funds tracked by Wall St. Rank hold BSTC as of Q4 2014.

  • McKinley Capital Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2014 after selling out during the quarter.
  • McKinley Capital Management sold 33,615 BioSpecifics Technologies Corp. shares in Q4 2014, an estimated $1.19M.
  • McKinley Capital Management first reported a position in BioSpecifics Technologies Corp. in Q3 2014 and held it in 1 quarter.
  • McKinley Capital Management's BioSpecifics Technologies Corp. position peaked at $1.19M in Q3 2014.
  • 85 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2014.

Based on McKinley Capital Management's 13F filing for Q4 2014, filed 4 Feb 2015.